Schedule 13D ownership disclosure

AILERON THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A105

Event date: 2019-04-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,079,394
Percent of class
7.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-019491
Form type
SC 13D/A
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Apr 03, 2019
Reporting period
Apr 02, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub